These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37951494)

  • 41. Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience.
    Fornaro A; Olivotto I; Rigacci L; Ciaccheri M; Tomberli B; Ferrantini C; Coppini R; Girolami F; Mazzarotto F; Chiostri M; Milli M; Marchionni N; Castelli G
    Eur J Heart Fail; 2018 May; 20(5):898-906. PubMed ID: 29148208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved anti-tumor response rate with decreased cardiotoxicity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who had received prior adjuvant doxorubicin: results of a retrospective analysis.
    Batist G; Harris L; Azarnia N; Lee LW; Daza-Ramirez P
    Anticancer Drugs; 2006 Jun; 17(5):587-95. PubMed ID: 16702817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer.
    Cheuk DK; Sieswerda E; van Dalen EC; Postma A; Kremer LC
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008011. PubMed ID: 27552363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Statins as preventive therapy for anthracycline cardiotoxicity: a meta-analysis of randomized controlled trials.
    D'Amario D; Laborante R; Bianchini E; Galli M; Ciliberti G; Mennuni M; Patti G
    Int J Cardiol; 2023 Nov; 391():131219. PubMed ID: 37527752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Spatial Ventricular Gradient Is an Independent Predictor of Anthracycline-Associated Cardiotoxicity.
    Rosas Diaz AN; Stabenau HF; Pajares Hurtado G; Warack S; Waks JW; Asnani A
    JACC Adv; 2023 Mar; 2(2):100269. PubMed ID: 38938305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is There a Cardiotoxicity Associated With Metallic Head Hip Prostheses? A Cohort Study in the French National Health Insurance Databases.
    Lassalle M; Colas S; Rudnichi A; Zureik M; Dray-Spira R
    Clin Orthop Relat Res; 2018 Jul; 476(7):1441-1451. PubMed ID: 29698302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sex-Specific Cardiovascular Risks of Cancer and Its Therapies.
    Wilcox NS; Rotz SJ; Mullen M; Song EJ; Ky Hamilton B; Moslehi J; Armenian SH; Wu JC; Rhee JW; Ky B
    Circ Res; 2022 Feb; 130(4):632-651. PubMed ID: 35175846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low-Dose Anthracycline and Risk of Heart Failure in a Pharmacokinetic Model of Human Myocardium Exposure: Analog Specificity and Role of Secondary Alcohol Metabolites.
    Salvatorelli E; Menna P; Chello M; Covino E; Minotti G
    J Pharmacol Exp Ther; 2018 Feb; 364(2):323-331. PubMed ID: 29222131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An Exploration of Heart Failure Risk in Breast Cancer Patients Receiving Anthracyclines with or without Trastuzumab in Thailand: A Retrospective Study.
    Yoodee J; Sookprasert A; Sanguanboonyaphong P; Chanthawong S; Seateaw M; Subongkot S
    Clin Pract; 2021 Aug; 11(3):484-493. PubMed ID: 34449564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Association of Metformin With Heart Failure in Patients With Diabetes Mellitus Receiving Anthracycline Chemotherapy.
    Onoue T; Kang Y; Lefebvre B; Smith AM; Denduluri S; Carver J; Fradley MG; Chittams J; Scherrer-Crosbie M
    JACC CardioOncol; 2023 Oct; 5(5):674-682. PubMed ID: 37969650
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients.
    Ruiz-Pinto S; Pita G; Martín M; Alonso-Gordoa T; Barnes DR; Alonso MR; Herraez B; García-Miguel P; Alonso J; Pérez-Martínez A; Cartón AJ; Gutiérrez-Larraya F; García-Sáenz JA; Benítez J; Easton DF; Patiño-García A; González-Neira A
    Breast Cancer Res Treat; 2018 Jan; 167(1):249-256. PubMed ID: 28913729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of long-term cardiotoxicity and evolution of the systolic function in patients with breast cancer treated with anthracyclines.
    Mata Caballero R; Serrano Antolín JM; Jiménez Hernández RM; Talavera Calle P; Curcio Ruigómez A; Del Castillo Arrojo S; Graupner Abad C; Cristóbal Varela C; Alonso Martín JJ
    Cardiol J; 2022; 29(2):228-234. PubMed ID: 32329038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
    van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
    JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology of anthracycline cardiotoxicity in children and adults.
    Grenier MA; Lipshultz SE
    Semin Oncol; 1998 Aug; 25(4 Suppl 10):72-85. PubMed ID: 9768828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: echocardiographic follow-up.
    Elbl L; Hrstkova H; Tomaskova I; Michalek J
    Support Care Cancer; 2006 Feb; 14(2):128-36. PubMed ID: 16034614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardioprotective effect of Platycodon grandiflorum in patients with early breast cancer receiving anthracycline-based chemotherapy: study protocol for a randomized controlled trial.
    Hao W; Liu S; Qin Y; Sun C; Chen L; Wu C; Bao Y
    Trials; 2017 Aug; 18(1):386. PubMed ID: 28830541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myocardial Strain Is Associated with Adverse Clinical Cardiac Events in Patients Treated with Anthracyclines.
    Ali MT; Yucel E; Bouras S; Wang L; Fei HW; Halpern EF; Scherrer-Crosbie M
    J Am Soc Echocardiogr; 2016 Jun; 29(6):522-527.e3. PubMed ID: 27068546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML.
    Creutzig U; Diekamp S; Zimmermann M; Reinhardt D
    Pediatr Blood Cancer; 2007 Jun; 48(7):651-62. PubMed ID: 17183582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.
    Feijen EA; Leisenring WM; Stratton KL; Ness KK; van der Pal HJ; Caron HN; Armstrong GT; Green DM; Hudson MM; Oeffinger KC; Robison LL; Stovall M; Kremer LC; Chow EJ
    J Clin Oncol; 2015 Nov; 33(32):3774-80. PubMed ID: 26304888
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of cardiotoxicity induced by adjuvant anthracycline-based chemotherapy and radiotherapy in young and old Asian women with breast cancer.
    Lee CH; Zhang JF; Yuan KS; Wu ATH; Wu SY
    Strahlenther Onkol; 2019 Jul; 195(7):629-639. PubMed ID: 30690687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.